デフォルト表紙
市場調査レポート
商品コード
988426

DNAシーケンシング製品市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2021年~2026年)

DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 112 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.68円
DNAシーケンシング製品市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2021年~2026年)
出版日: 2021年02月02日
発行: IMARC Services Private Limited
ページ情報: 英文 112 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDNAシーケンシング製品の市場規模は、2020年に50億1000万米ドルに達しました。

微生物のゲノムマッピングと配列決定により、農業従事者はそれらを作物や食用植物に使用できるようになりました。過去数年にわたって、細菌の特定の遺伝子は、昆虫や害虫に対する耐性を向上させるために食品植物で使用されており、生産性と栄養価が向上しています。これに加えて、鶏、豚、牛、羊、馬などのいくつかの家畜のゲノムも部分的または完全に配列決定されており、肉や牛乳の品質が向上した家畜の生産に役立つことが証明されています。

特にPoC (ポイントオブケア) 診断のための体外診断市場におけるDNAシーケンシングの役割は勢いを増すと予想されます。 DNAシーケンシングは、患者に特定の治療法や治療法を提供するための精密医療の開発を可能にします。また、PoCでのDNAデータの遺伝子配列決定と分析を高精度で迅速に診断できる、様々なプラットフォームを提供します。

研究者と装置メーカーは、低コスト・高精度・高速なシーケンスを提供する一連のDNAシーケンス技術を生み出しました。たとえば、この分野の主力企業であるIlluminaは、10個の超ハイスループットシーケンサーで構成され、年間約18,000のヒトゲノムをシーケンスできるシステムを立ち上げました。

研究者たちは現在、ゲノムマッピングに革新的な技術を使用しており、完了までの時間が短縮されています。これ以外に、シーケンスコストの削減により、多くの企業が研究開発 (R&D) 活動に投資し、全ゲノムシーケンス、de novoシーケンス、特定の疾患診断などの費用効果の高いソリューションを提供するようになりました。

当レポートでは、世界のDNAシーケンシング製品市場の構造と動向について分析し、市場の全体的構造や、市場規模の推移・予測、製品種類別・用途別・エンドユーザー別・地域別の詳細動向、市場の求心力・競争情勢、主要企業のプロファイルなどについて調査しております。

目次

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のDNAシーケンシング製品市場

  • 市場概要
  • 市場規模の実績値
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • 市場区分:製品種類別
  • 市場区分:用途別
  • 市場区分:エンドユーザー別
  • 市場区分:技術別
  • 市場区分:地域別
  • SWOT分析
  • バリューチェーン分析
    • 研究開発
    • 原材料調達
    • 製造
    • 流通
    • 最終用途
  • ポーターのファイブフォース分析

第6章 製品種類別の市場区分

  • 消耗品・試薬
  • 分析装置

第7章 用途別の市場区分

  • バイオマーカー
  • 診断
  • リプロダクティブ・ヘルス
  • フォレンジック
  • 個別化医療
  • その他

第8章 エンドユーザー別の市場区分

  • 教育・政府研究機関
  • 製薬・バイオテクノロジー企業
  • 病院・クリニック
  • その他

第9章 地域別の市場区分

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Illumina Inc
    • Thermo Fisher Scientific Inc.
    • Roche Diagnostics
    • Pacific Biosciences of California, Inc.
    • Beckman Coulter
図表

List of Figures

  • Figure 1: Global: DNA Sequencing Products Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Sequencing Products Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: DNA Sequencing Products Market: Breakup by Product Type (in %), 2020
  • Figure 4: Global: DNA Sequencing Products Market: Breakup by Application (in %), 2020
  • Figure 5: Global: DNA Sequencing Products Market: Breakup by End-User (in %), 2020
  • Figure 6: Global: DNA Sequencing Products Market: Breakup by Technology (in %), 2020
  • Figure 7: Global: DNA Sequencing Products Market: Breakup by Region (in %), 2020
  • Figure 8: Global: DNA Sequencing Products Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: DNA Sequencing Industry: SWOT Analysis
  • Figure 10: Global: DNA Sequencing Products Industry: Value Chain Analysis
  • Figure 11: Global: DNA Sequencing Products Industry: Porter's Five Forces Analysis
  • Figure 12: Global: DNA Sequencing Products Market: Consumables and Reagents (in Million US$), 2015 & 2020
  • Figure 13: Global: DNA Sequencing Products Market Forecast: Consumables and Reagents (in Million US$), 2021-2026
  • Figure 14: Global: DNA Sequencing Products Market: Equipments (in Million US$), 2015 & 2020
  • Figure 15: Global: DNA Sequencing Products Market Forecast: Equipments (in Million US$), 2021-2026
  • Figure 16: Global: DNA Sequencing Products Market (Applications in Biomarkers): Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: DNA Sequencing Products Market Forecast (Applications in Biomarkers): Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: DNA Sequencing Products Market (Applications in Diagnostics): Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: DNA Sequencing Products Market Forecast (Applications in Diagnostics): Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: DNA Sequencing Products Market (Application in Reproductive Health): Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: DNA Sequencing Products Market Forecast (Applications in Reproductive Health): Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: DNA Sequencing Products Market (Applications in Forensics): Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: DNA Sequencing Products Market Forecast (Applications in Forensics): Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: DNA Sequencing Products Market (Applications in Personalized Medicine): Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: DNA Sequencing Products Market Forecast (Applications in Personalized Medicine): Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: DNA Sequencing Products Market (Other Applications): Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: DNA Sequencing Products Market Forecast (Other Applications): Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: DNA Sequencing Products Market (in Academic and Government Research Institutes): Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: DNA Sequencing Products Market Forecast (in Academic and Government Research Institutes): Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: DNA Sequencing Products Market (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: DNA Sequencing Products Market Forecast (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: DNA Sequencing Products Market (in Hospitals and Clinics): Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: DNA Sequencing Products Market Forecast (in Hospitals and Clinics): Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: DNA Sequencing Products Market (Other End-Use): Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: DNA Sequencing Products Market Forecast (Other End-Use): Sales Value (in Million US$), 2021-2026
  • Figure 36: North America: DNA Sequencing Products Market: Sales Value (in Million US$) 2015 & 2020
  • Figure 37: North America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$) 2021-2026
  • Figure 38: Europe: DNA Sequencing Products Market: Sales Value (in Million US$) 2015 & 2020
  • Figure 39: Europe: DNA Sequencing Products Market Forecast: Sales Value (in Million US$) 2021-2026
  • Figure 40: Asia Pacific: DNA Sequencing Products Market: Sales Value (in Million US$) 2015 & 2020
  • Figure 41: Asia Pacific: DNA Sequencing Products Market Forecast: Sales Value (in Million US$) 2021-2026
  • Figure 42: Latin America: DNA Sequencing Products Market: Sales Value (in Million US$) 2015 & 2020
  • Figure 43: Latin America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$) 2021-2026
  • Figure 44: Middle East and Africa: DNA Sequencing Products Market: Sales Value (in Million US$) 2015 & 2020
  • Figure 45: Middle East and Africa: DNA Sequencing Products Market Forecast: Sales Value (in Million US$) 2021-2026
  • Figure 46: Global: DNA Sequencing Products Market: Breakup by Key Players (in %), 2020

List of Tables

  • Table 1: Global: DNA Sequencing Products Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: DNA Sequencing Products Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 3: Global: DNA Sequencing Products Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 4: Global: DNA Sequencing Products Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 5: Global: DNA Sequencing Products Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: DNA Sequencing Products Market: Competitive Structure
  • Table 7: Global: DNA Sequencing Products Market: Key Players
目次
Product Code: SR1020A161_Report

The global DNA sequencing products market reached a value of US$ 5.01 Billion in 2020. DNA sequencing is the process used for calculating the precise sequence of the four nucleotide bases within a DNA molecule, namely, cytosine, adenine, thymine and guanine. It plays an important role in mapping out the human genome as well as helps in various applied research applications. In line with this, DNA sequencing products are gaining popularity in the pharmaceutical industry as they assist researchers in understanding complex diseases and, in turn, develop personalised medicines for patients. Additionally, DNA profiling has become an integral part of forensic science as these profiles enable investigators to identify and distinguish multiple samples from a pool of DNA. Looking forward, IMARC Group expects the global DNA sequencing products market to exhibit strong growth during the next five years.

Global DNA Sequencing Products Market Drivers:

  • Genome mapping and sequencing of microorganisms have enabled agriculturists to use them for crops and food plants. Over the past few years, specific genes of bacteria have been used in food plants to improve their resistance against insects and pests which has increased their productivity and nutritional value. In addition to this, genomes of several domesticated livestock animals, such as chicken, pig, cow, sheep, and horse, have also been partially or completely sequenced and proven to be useful in the production of livestock with enhanced quality of meat and milk.
  • The role of DNA sequencing in the in-vitro diagnostics market, particularly for point-of-care diagnostics, is expected to gain momentum. DNA sequencing enables the development of precision medicine in order to offer specific treatments or therapies to patients. It also provides various platforms that enable genetic sequencing and analysis of DNA data at the point-of-care with high accuracy and rapid diagnosis.
  • Researchers and instrument developers have produced an array of DNA sequencing technologies which offer faster sequencing with higher accuracy at lower costs. For instance, one of the primary market players in the field, Illumina, has launched a system that consists of 10 ultra-high-throughput sequencers and can sequence about 18,000 human genomes per year.
  • Researchers are now using innovative technologies for genome mapping that take lesser time for completion. Other than this, the reduction in sequencing costs has led many companies to invest in R&D activities and offer cost-effective solutions such as whole genome sequencing, de novo sequencing and specific disease diagnosis.

Breakup by Product Type:

  • On the basis of the product type, the market has been segmented into consumables and reagents, and equipments. Currently, consumables and reagents represent the largest segment as they generate a higher return-on-investments.

Breakup by Application:

  • DNA sequencing products find applications across various sectors including biomarkers, diagnostics, reproductive health, personalised medicine and forensics. Amongst these, biomarkers are the most popular application segment of DNA sequencing products as they help in predicting treatment outcomes.

Breakup by End-User:

  • Based on the end-user, the market has been segregated into academic and government research institutes, pharmaceutical and biotechnology companies, and hospitals and clinics. At present, DNA sequencing is majorly being used in academic and government research institutes owing to the presence of a large number of research and development projects which involve the practical implementation of data analysis and next-generation sequencing.

Regional Insights:

  • On a geographical front, North America accounts for the majority of the total global DNA sequencing products market. This can be accredited to the growing geriatric population, prevalence of several chronic diseases and presence of prominent drug manufacturers in the region. North America is followed by Europe, Asia Pacific, Latin America, and Middle East and Africa.

Competitive Landscape:

The nature of the market is fragmented with the presence of numerous small and large manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Pacific Biosciences of California, Inc.
  • Beckman Coulter

Key Questions Answered in This Report:

  • How has the global DNA sequencing products market performed so far and how will it perform in the coming years?
  • What are the key regions in the global DNA sequencing products market?
  • What has been the impact of COVID-19 on the global DNA sequencing products market?
  • Which are the popular product types in the global DNA sequencing products market?
  • What are the key application segments in the global DNA sequencing products market?
  • What are the major end-use sectors in the global DNA sequencing products market?
  • What are the various stages in the value chain of the global DNA sequencing products market?
  • What are the key driving factors and challenges in the global DNA sequencing products market?
  • What is the structure of the global DNA sequencing products market and who are the key players?
  • What is the degree of competition in the global DNA sequencing products market?
  • How are DNA sequencing products manufactured?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Sequencing Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Technology
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Research and Development
    • 5.11.2 Raw Material Procurement
    • 5.11.3 Manufacturing
    • 5.11.4 Distribution
    • 5.11.5 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Consumables and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biomarkers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Reproductive Health
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Forensics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Personalized Medicine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Academic and Government Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Market Breakup by Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Illumina Inc
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 Thermo Fisher Scientific Inc.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Roche Diagnostics
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Pacific Biosciences of California, Inc.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Beckman Coulter
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio
      • 10.3.5.4 Financials
      • 10.3.5.5 SWOT Analysis